Biosynex announced today that it has been awarded the 1st prize for innovation in the Biotech & Life Science category and the 1st Euronext Best Growth Award of the Deloitte In Extenso Technology Fast 50, which recognizes high-growth technology companies. This ranking is based on the growth rate of sales over the last four years, between 2013 and 2016. Over this period, Biosynex achieved a growth rate of 1,384%.
“These prestigious awards recognize the hard work and involvement of our teams on a daily basis to make Biosynex one of France’s most successful achievements in its field.” The Deloitte In Extenso Technology Fast 50 confirms the innovation strategy put in place by Biosynex to achieve this level of excellence required to claim this coveted award. ” says Larry Abensur, CEO of Biosynex.
“Confidence in investors and the market, Deloitte’s Technology Fast 50 list is proof of the dynamism and innovation capacity of French companies. We are convinced that these technological companies will tomorrow be the spearheads of our economy and the catalysts for a growth dynamic that creates jobs and value. It is with great pride that we award these prizes to Biosynex, the winner of the 2017 edition, “says Ariane Bucaille, Deloitte Partner in charge of Technology Fast 50.